ProfileGDS4132 / 1494_f_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 72% 66% 74% 75% 72% 68% 71% 63% 72% 75% 77% 75% 72% 71% 75% 69% 69% 65% 75% 73% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101220.16972
GSM201543Muscle PCOS pioglitazone 121180.99666
GSM201544Muscle PCOS pioglitazone 161237.25474
GSM201545Muscle PCOS pioglitazone 201257.52975
GSM201829Muscle PCOS pioglitazone 231233.15272
GSM201830Muscle PCOS pioglitazon 251207.03968
GSM201831Muscle PCOS pioglitazone 271224.07771
GSM201832Muscle PCOS pioglitazone 31171.04363
GSM201833Muscle PCOS pioglitazone 41207.94572
GSM201834Muscle PCOS pioglitazone 81238.08675
GSM201835Muscle PCOS after pioglitazone 102253.46877
GSM201836Muscle PCOS after pioglitazone 122237.83175
GSM201837Muscle PCOS after pioglitazone 162204.64272
GSM201838Muscle PCOS after pioglitazone 202212.24671
GSM201839Muscle PCOS after pioglitazone 232244.5275
GSM201840Muscle PCOS after pioglitazone 252205.73469
GSM201841Muscle PCOS after pioglitazone 272190.47269
GSM201842Muscle PCOS after pioglitazone 32161.17565
GSM201843Muscle PCOS after pioglitazone 42232.75975
GSM201844Muscle PCOS after pioglitazone 82234.6673